Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Net Income

Bottom-line profit after all expenses, interest, and taxes.

Organigram Global Inc.NASDAQ: OGI

Net Income · Q2 FY2026 · quarter ended Mar 2026

Net income turns negative

Q2 FY2026 net income was -CA$921K, compared with CA$42.46M a year earlier. Trailing-twelve-month net income was -CA$25.23M.

Context

  • Net income amounted to 9.6% of revenue in FY2025, down 18.9 pp from a year earlier.
  • Net income grew in size in 1 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of CA$70.73M (+497.9%) for the fiscal year ending Sep 2026, a step up from the +60.9% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$921K-104.6% QoQ
Last fiscal yearSep 2025
-CA$17.78M+60.9% YoY
LTMMar 2026
-CA$25.23M-249.4% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-102.2%+84.8%+187.0 pp
1 year+60.9%+497.9%+437.0 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CAD · from the income statement

Latest · FY2025
(17.78M) CAD
Year-over-year change
+60.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -249.4% is the 6th highest of 9, against a peer median of -50.1%.
  • Net income amounts to 9.2% of revenue for OGI, versus a peer median of 25.2%.
OGI Competitors
Net Income for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ELMDElectromed, Inc.LTM Mar 2026$10.1M USD+41.1%+48.4%14.1%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$7.91M USD+148.0%+616.7%5.6%
DERMJourney Medical CorporationLTM Mar 2026-$9.59M USD-15.5%—14.8%
OGIOrganigram Global Inc.LTM Mar 2026-CA$25.23M CAD-249.4%—9.2%
LFCRLifecore Biomedical, Inc.LTM Mar 2026-$34.09M USD——25.2%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026-$54.64M USD+17.6%—167.0%
ACBAurora Cannabis Inc.LTM Mar 2026-CA$75.03M CAD-4815.8%—24.1%
HSDTSolana CompanyLTM Mar 2026-$136.85M USD-947.5%—1427.1%
RNACCartesian Therapeutics, Inc.LTM Mar 2026-$151.77M USD-296.2%—8550.6%
IVAInventiva S.A.FY2025-€340.16M EUR-84.7%—7587.8%
Peer median (excluding OGI) —-50.1%+332.6%25.2%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.